EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹1,377 Cr | ₹905 Cr | ₹868 Cr | ₹883 Cr | ₹899 Cr |
What is the latest Total Non-Current Liabilities ratio of EMCURE PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹1,377 Cr |
Mar2023 | ₹905 Cr |
Mar2022 | ₹868 Cr |
Mar2021 | ₹883 Cr |
Mar2020 | ₹899 Cr |
How is Total Non-Current Liabilities of EMCURE PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,377 Cr | 52.24 | |
Mar2023 | ₹905 Cr | 4.16 | |
Mar2022 | ₹868 Cr | -1.64 | |
Mar2021 | ₹883 Cr | -1.80 | |
Mar2020 | ₹899 Cr | - |
Compare Total Non-Current Liabilities of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹27,011.3 Cr | 4.5% | 6.2% | 0.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,620.0 Cr | -1.3% | 1% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,509.0 Cr | -3.2% | -0.3% | 48% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,571.0 Cr | 1.2% | 10.7% | 19.5% | Stock Analytics | |
CIPLA | ₹118,336.0 Cr | -0.6% | -2.2% | -0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,522.0 Cr | -1.5% | -5.9% | -5.1% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 4.5% |
6.2% |
0.3% |
SENSEX | -0.5% |
-0.3% |
1% |
You may also like the below Video Courses